Eli Lilly cuts surprising deals with upstart biotech players
Eli Lilly stock reached a new 52-week high on Nov. 10, up 4.7% and extending a month-long rally of 16%, after the pharmaceutical giant announced two
(TheStreet, 2025-11-11T00:00:00Z)